Generated: May 28, 2017
|Abstract:||The invention relates to aqueous pharmaceutical formulations comprising human growth hormone, histidine, poloxamer, phenol, and mannitol.|
|Inventor(s):||Bjorn; Soren (Lyngby, DK), Sorensen; Hans Holmegaard (Virum, DK), Langballe; Peter (Charlottenlund, DK), Larsen; Silke Moller (Charlottenlund, DK), Ebbehoj; Kristen (N.ae butted.rum, DK), Hansen; Birthe Lykkegaard (V.ae butted.rlose, DK)|
|Assignee:||Novo Nordisk Health Care AG (Zurich, CH)|
1. An aqueous pharmaceutical formulation comprising a) about 1 mg/ml to about 15 mg/ml of human growth hormone (hGH), b) histidine in an amount of about 0.05-about 0.5
mg per mg hGH, c) Poloxamer 188 in an amount of about 0.1-about 2 mg per mg hGH, d) mannitol in an isotonicity conferring amount, and e) phenol in an amount that confers a preservative effect, wherein the formulation has a pH 6.0-6.2, and wherein the hGH
is dissolved in said formulation.
2. The formulation of claim 1, wherein the formulation has a pH of about 6.1.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.